Abstract
Present study aims to establish erythrocyte oxidant/antioxidant status in diabetic patients with and without atherosclerotic complications. Fasting blood samples were obtained from 23 diabetic and 12 control subjects. Thirteen patients had no disease other than diabetes mellitus and 10 patients had also atherosclerosis in addition to diabetes mellitus. Erythrocyte antioxidant potential (AOP) and thiobarbituric acid reagent substances (TBARS) levels were measured in these patients and results were compared with those of controls, who were chosen among healthy subjects. Results suggest that although there is an oxidant stress in the erythrocytes of diabetics, this is not due to reduced erythrocyte antioxidant defence potential but, rather, increased free radical production possibly due to hyperglycemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sundaram R.K., Bhaskar A., Vijayalinbam S., Viswanathan M., Mohan R., Shantnugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes, mellitus with and without complications. Clin. Sci. 1996, 90: 255–260.
Uzel N., Sivas A, Uysal M., Oz H. Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus Horm. Metabol. Res. 1987, 19: 89–90.
Haffner S.M., Agil A., Mykkanen L., Stern M.P., Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDMT. Diabetes Care 1995, 18: 646–653.
Selvam R., Anuradha C.V. Lipid peroxidation and antiperoxidative enzyme changes in erythrocytes in diabetes mellitus. Indian J. Biochem. Bio. 1988, 25: 268–272.
Willems D., Dorchy H., Dufrasne D. Serum antioxidant status and oxidized LDL in wellcontrolled young type 1 diabetic patients with and without subclinical complications. Atherosclerosis 1998, 137 (Suppl.): S61–S64.
Durak I, Karabacak H.I., Büyükkoçak S., Cimen M.Y.B., Kaçmaz M., Ömeroĝlu E., Öztürk H.S. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine. Nephron 1998, 78: 207–211.
Van Ye T.M., Roza A.M., Pieper G.M., Henderson Jr. J., Johnson C.P., Adams M.B. Inhibition of intestinal lipid peroxidation does not minimize morphological damage J. Surg. Res. 1993, 55: 553–558.
Loebstein R., Lehotay D.C., Luo X., Bartfay W., Tyler B., Sher G.D. Diabetic nephropathy in hypertransfused patients with beta-thalassemia. The role of oxidative stress. Diabetes Care 1998, 21: 1306–1309.
Zukowska-Szczechowska E., Grzeszczak W., Lacka B. The role of oxidative stress in development of diabetic angiopathies. Wiad. Lek. 1998, 51 (Suppl.) 2: 35–39.
Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., Tonutti L., Taboga C. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care 1998, 21: 1529–1533.
Delmas-Beauvieux M.C., Peuchant E., Thomas M.I., Dubourg L., Pinto A.P., Clerc M. Gin H. The place of electron spin resonance methods in the detection of oxidative stress in type 2 diabetes with poor glycemic control. Clin. Biochem. 1998, 31: 221–228.
Losada M., Alio J.L. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc. Ophthalmol. 1996/97, 93: 223–229.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Büyükkoçak, S., Öztürk, H.S., Tamer, M.N. et al. Erythrocyte oxidant/antioxidant status of diabetic patients. J Endocrinol Invest 23, 228–230 (2000). https://doi.org/10.1007/BF03343712
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343712